Pharmacogenetic Screening: A Cost-Effective Str...

By Staff Writer

September 12, 2024

Introduction Major Depressive Disorder (MDD) is a significant public health issue, affecting around 3.8% of the global population. This translates to approximately 300 million people according to the
Addressing Financial Hardship in Healthcare: A Focus on Older Informal Worker...
Modernising AI Medical Devices Regulation: FDA’s Firm-Based Approach
Innovative Funding Models for Non-Communicable Diseases
The Evolution of Consent in Biomedical AI: Ensuring Privacy and Equity
Enhancing Surgical Recovery Predictions with AI: A New Approach
Enhancing Clinician Accuracy in EEG Pattern Classification with AI
The Power of Real-World Evidence: Bringing Everyday Health Data to Drug Appro...
The Future of Peer Review in Scientific Manuscripts: Embracing Artificial Int...
Treatment Effect Estimation with AI: The CURE Framework
Insights into Austria’s Pricing and Pharmaceutical Policy
Advancing Healthcare: The Role of Real-World Evidence in Decision-Making
The ‘black box’ Phenomenon in Artificial Intelligence